1 completed, 1 recruiting, 1 terminated. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Recruiting 1, Terminated 1 |
Follow Contrast Media: new trials by email Literature Review of Contrast Media trials Research Report on Contrast Media
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years Motor Tests, Cognitive Tests, Unenhanced-MRI of the brain - Motor Function, Cognitive Function | Phase 4 | Recruiting | Guerbet | 2076 | 2021-03-24 | 2026-01-22 |
| Primovist / Eovist in Renally Impaired Patients Gadoxetic acid disodium (Primovist, BAY86-4873) - Contrast Media | Phase 4 | Completed | Bayer | 357 | 2009-05-01 | 2015-07-23 |
| Bicarbonate v Saline to Prevent Contrast Nephropathy 0.9% (154 mEq/L) IV Sodium Chloride, 1/6 M (166 mEq/L) IV Sodium Bicarbonate - Kidney Failure, Acute, Contrast Media | Phase 4 | Terminated | Italian Society of Nephrology | 61 | 2006-12-01 | 2010-12-01 |
Acute Kidney Injury (1) · Breast Neoplasms (1) · Carcinoma, Hepatocellular (1) · Cardiovascular Diseases (1) · Colorectal Neoplasms (1) · Kidney Failure, Chronic (1) · Nephrogenic Fibrosing Dermopathy (1) · Neuroendocrine Tumors (1) · Prostatic Neoplasms (1) · Renal Insufficiency, Chronic (1)
Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2) · Urogenital Diseases (2) · Adenocarcinoma (1) · Breast Diseases (1) · Carcinoma (1) · Chronic Disease (1) · Colonic Diseases (1) · Digestive System Diseases (1) · Digestive System Neoplasms (1) · Disease Attributes (1) · Female Urogenital Diseases (1)
gadolinium ethoxybenzyl DTPA (2) · Neuropsychological Tests (1) · Sodium Bicarbonate (1) · Sodium Chloride (1) · gadobenic acid (1) · gadobutrol (1) · gadodiamide (1) · gadoterate meglumine (1) · gadoteridol (1)
Bayer (1) · Guerbet (1) · Italian Society of Nephrology (1)
Italy (3) · Germany (2) · South Korea (2) · United States (2) · Australia (1) · Austria (1) · Brazil (1) · Canada (1) · France (1) · Russia (1) · Spain (1) · Thailand (1) · United Kingdom (1)
Brendan BJ Barrett, MD, MSc (1) · Ferruccio Conte, MD (1) · Pietro Ravani, MD, MSc (1)
2008 (1)